Advanced in Congenital Hyperinsulinism

Dr. Amy Fleischman

Pediatric Endocrinology
Division Of Endocrinology
333 Longwood Ave, 
Boston, MA 

Advanced in Congenital Hyperinsulinism
Division Of Endocrinology
333 Longwood Ave, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Amy Fleischman is a Pediatric Endocrinologist in Boston, Massachusetts. Dr. Fleischman is rated as an Advanced provider by MediFind in the treatment of Congenital Hyperinsulinism. Her top areas of expertise are Short Stature (Growth Disorders), Obesity, Familial Short Stature (FSS), and Idiopathic Short Stature (ISS).

Her clinical research consists of co-authoring 13 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Congenital Hyperinsulinism.

Specialties
Pediatric Endocrinology
Licenses
Pediatrics in MA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health New England
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
NH Healthy Families
  • EPO
  • MANAGED MEDICAID PLAN
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Division of Endocrinology
333 Longwood Ave, Boston, MA 02115
Call: 617-919-5323

Additional Areas of Focus

Dr. Fleischman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)
Pediatric Growth Hormone Deficiency

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

An Open-Label, Long-Term Safety and Efficacy Evaluation of Diazoxide Choline Extended-Release Tablets in Participants With Prader-Willi Syndrome With a Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
An Open-Label, Long-Term Safety and Efficacy Evaluation of Diazoxide Choline Extended-Release Tablets in Participants With Prader-Willi Syndrome With a Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
Enrollment Status: Completed
Publish Date: April 19, 2024
Intervention Type: Drug
Study Drug: DCCR (diazoxide choline controlled release tablets)
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
Phase 3, Randomized, Double-Blind, Placebo-Controlled, 8-week Clinical Study to Assess the Efficacy, Safety, and Tolerability, of Intranasal Carbetocin (LV-101) in Prader-Willi Syndrome (PWS) With Long Term Follow-Up (CARE-PWS)
Phase 3, Randomized, Double-Blind, Placebo-Controlled, 8-week Clinical Study to Assess the Efficacy, Safety, and Tolerability, of Intranasal Carbetocin (LV-101) in Prader-Willi Syndrome (PWS) With Long Term Follow-Up (CARE-PWS)
Enrollment Status: Completed
Publish Date: July 26, 2022
Intervention Type: Drug
Study Drug: Intranasal carbetocin
Study Phase: Phase 3
View 2 Less Clinical Trials

13 Total Publications

Overfeeding and overweight rapidly reprogram inflammatory signaling.
Overfeeding and overweight rapidly reprogram inflammatory signaling.
Journal: Clinical immunology (Orlando, Fla.)
Published: October 30, 2024
View All 13 Publications
Similar Doctors
Distinguished in Congenital Hyperinsulinism
Dr. Dorit Koren
Pediatric Endocrinology
Distinguished in Congenital Hyperinsulinism
Dr. Dorit Koren
Pediatric Endocrinology

MGFC Division Of Adolescent And Young Adult Medicine

55 Fruit St Ste 6C, 
Boston, MA 
 (2.6 miles away)
617-726-2909
Languages Spoken:
English
See accepted insurances

Dorit Koren is a Pediatric Endocrinologist in Boston, Massachusetts. Dr. Koren is rated as an Advanced provider by MediFind in the treatment of Congenital Hyperinsulinism. Her top areas of expertise are Congenital Hyperinsulinism, Obesity, Obesity in Children, and Type 2 Diabetes (T2D).

Advanced in Congenital Hyperinsulinism
Dr. Swathi Sethuram
Pediatric Endocrinology
Advanced in Congenital Hyperinsulinism
Dr. Swathi Sethuram
Pediatric Endocrinology

Mass General For Children Specialties

54 Baker Avenue Ext Ste 302, 
Concord, MA 
 (15.8 miles away)
978-287-8503
Languages Spoken:
English
See accepted insurances

Swathi Sethuram is a Pediatric Endocrinologist in Concord, Massachusetts. Dr. Sethuram is rated as an Advanced provider by MediFind in the treatment of Congenital Hyperinsulinism. Her top areas of expertise are Congenital Hyperinsulinism, Obesity in Children, Addison's Disease, and Pediatric Growth Hormone Deficiency.

Advanced in Congenital Hyperinsulinism
Dr. Melissa Crocker
Pediatric Endocrinology
Advanced in Congenital Hyperinsulinism
Dr. Melissa Crocker
Pediatric Endocrinology

Division Of Endocrinology

333 Longwood Ave, 
Boston, MA 
 (0.1 miles away)
617-919-5323
Languages Spoken:
English
See accepted insurances

Melissa Crocker is a Pediatric Endocrinologist in Boston, Massachusetts. Dr. Crocker is rated as an Advanced provider by MediFind in the treatment of Congenital Hyperinsulinism. Her top areas of expertise are Short Stature (Growth Disorders), Obesity in Children, Obesity, Type 1 Diabetes (T1D), and Orchiectomy.

VIEW MORE CONGENITAL HYPERINSULINISM DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fleischman's expertise for a condition
ConditionClose
      • Advanced
      • Congenital Hyperinsulinism
        Dr. Fleischman is
        Advanced
        . Learn about Congenital Hyperinsulinism.
        See more Congenital Hyperinsulinism experts
      • Congenital Hypothyroidism
        Dr. Fleischman is
        Advanced
        . Learn about Congenital Hypothyroidism.
        See more Congenital Hypothyroidism experts
      • Diabetes Insipidus (DI)
        Dr. Fleischman is
        Advanced
        . Learn about Diabetes Insipidus (DI).
        See more Diabetes Insipidus (DI) experts
      • Familial Short Stature (FSS)
        Dr. Fleischman is
        Advanced
        . Learn about Familial Short Stature (FSS).
        See more Familial Short Stature (FSS) experts
      • Growth Hormone Deficiency (GHD)
        Dr. Fleischman is
        Advanced
        . Learn about Growth Hormone Deficiency (GHD).
        See more Growth Hormone Deficiency (GHD) experts
      • Hypogonadism
        Dr. Fleischman is
        Advanced
        . Learn about Hypogonadism.
        See more Hypogonadism experts
      View All 18 Advanced Conditions
      • Experienced
      • Acanthosis Nigricans
        Dr. Fleischman is
        Experienced
        . Learn about Acanthosis Nigricans.
        See more Acanthosis Nigricans experts
      • Addison's Disease
        Dr. Fleischman is
        Experienced
        . Learn about Addison's Disease.
        See more Addison's Disease experts
      • Albright's Hereditary Osteodystrophy
        Dr. Fleischman is
        Experienced
        . Learn about Albright's Hereditary Osteodystrophy.
        See more Albright's Hereditary Osteodystrophy experts
      • Cardiofaciocutaneous Syndrome
        Dr. Fleischman is
        Experienced
        . Learn about Cardiofaciocutaneous Syndrome.
        See more Cardiofaciocutaneous Syndrome experts
      • Cardiomyopathic Lentiginosis
        Dr. Fleischman is
        Experienced
        . Learn about Cardiomyopathic Lentiginosis.
        See more Cardiomyopathic Lentiginosis experts
      • Congenital Adrenal Hyperplasia (CAH)
        Dr. Fleischman is
        Experienced
        . Learn about Congenital Adrenal Hyperplasia (CAH).
        See more Congenital Adrenal Hyperplasia (CAH) experts
      View All 24 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.